跳至主要内容
临床试验/EUCTR2011-001488-40-IT
EUCTR2011-001488-40-IT进行中(未招募)不适用

Antiplatelet effect of low doses of aspirin taken every 12 hours in patients undergoing coronary artery bypass graft and / or aortic valve replacement surgery with bioprostheses

FONDAZIONE MONZINO CENTRO CARDIOLOGICO0 个研究点开始时间: 2012年3月6日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • informed consent of the study signed
  • coronary artery bypass graft and / or aortic valve replacement surgery with bioprostheses
  • age between 55 and 80
  • ejection fraction> 30%.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 45
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 54

排除标准

  • excessive bleeding (> 1000mL / 6 h) or the need of re operation for bleeding
  • perioperative myocardial infarction
  • stroke or renal failure requiring dialysis and need of post-operative anticoagulation
  • patients undergoing coronary artery bypass grafting procedure as a consequence of failed percutaneous coronary intervention
  • patients undergoing off-pump coronary artery bypass graft
  • overt kidney or liver disease
  • therapies that influence the coagulation
  • fertile women

研究者

发起方
FONDAZIONE MONZINO CENTRO CARDIOLOGICO

相似试验